Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “N0-2”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT00084396
What this trial is testing

Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Who this might be right for
Breast Cancer
Washington University School of Medicine 115
Large-scale testing (Phase 3)Study completedNCT01819285
What this trial is testing

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Who this might be right for
Neoplasm, Prostate
European Organisation for Research and Treatment of Cancer - EORTC 985
Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Not applicableStudy completedNCT03719833
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents

Who this might be right for
Breast CancerSentinel Lymph Node BiopsyNeoadjuvant Chemotherapy
Clinical Hospital Center Rijeka 230
Large-scale testing (Phase 3)Study completedNCT00232661
What this trial is testing

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

Who this might be right for
Breast Cancer
AstraZeneca 452
Testing effectiveness (Phase 2)Ended earlyNCT02891161
What this trial is testing

Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder

Who this might be right for
Urothelial Cancer
Monika Joshi, MD 26
Testing effectiveness (Phase 2)Study completedNCT00543829
What this trial is testing

German Preoperative Adriamycin Docetaxel Study

Who this might be right for
Breast Neoplasms
GBG Forschungs GmbH 250
Large-scale testing (Phase 3)Ended earlyNCT00207831
What this trial is testing

Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma

Who this might be right for
Rectal CancerStage II/IIIT3 or T4 (Only Anal Extension) Rectal Cancer+2 more
Institut Cancerologie de l'Ouest 219